Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis.
about
DNA vaccine constructs against enterovirus 71 elicit immune response in miceA clinically authentic mouse model of enterovirus 71 (EV-A71)-induced neurogenic pulmonary oedema.Emerging viral diseases of Southeast Asia and the Western PacificMolecular mechanism of SCARB2-mediated attachment and uncoating of EV71Human SCARB2-mediated entry and endocytosis of EV71Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore.Anti-SARS coronavirus agents: a patent review (2008 - present).Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activityAnimal models of enterovirus 71 infection: applications and limitations.Cell surface vimentin is an attachment receptor for enterovirus 71.A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein.Clinical characteristics and treatment of severe encephalitis associated with neurogenic pulmonary edema caused by enterovirus 71 in China.Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes.Proteomic analysis of extremely severe hand, foot and mouth disease infected by enterovirus 71Epidemiology and clinical characteristics of hand foot, and mouth disease in a Shenzhen sentinel hospital from 2009 to 2011Spatio-temporal clustering of hand, foot, and mouth disease at the county level in Guangxi, ChinaPhenotypic and genotypic characteristics of novel mouse cell line (NIH/3T3)-adapted human enterovirus 71 strains (EV71:TLLm and EV71:TLLmv).Co-circulation and genomic recombination of coxsackievirus A16 and enterovirus 71 during a large outbreak of hand, foot, and mouth disease in Central ChinaMassive pulmonary hemorrhage in enterovirus 71-infected hand, foot, and mouth disease.Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2.Characterization and specificity of the linear epitope of the enterovirus 71 VP2 proteinDetection of human enterovirus 71 and coxsackievirus A16 in children with hand, foot and mouth disease in China.Analysis on the sequence of the whole genome of an isolated enterovirus 71 strain.Comprehensive safety assessment of a human inactivated diploid enterovirus 71 vaccine based on a phase III clinical trialEnterovirus 71 2B Induces Cell Apoptosis by Directly Inducing the Conformational Activation of the Proapoptotic Protein BaxPicornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitors.Enterovirus 71 Neutralizing Antibodies Seroepidemiological Research among Children in Guangzhou, China between 2014 and 2015: A Cross-Sectional Study.Epidemiology of enteroviral meningoencephalitis in neonates and young infants.Phylogeography of Coxsackievirus A16 Reveals Global Transmission Pathways and Recent Emergence and Spread of a Recombinant Genogroup.In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection.Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western AustraliaWater extract of Glycyrrhiza uralensis inhibited enterovirus 71 in a human foreskin fibroblast cell line.Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group.A highly conserved amino acid in VP1 regulates maturation of enterovirus 71Development of duplex real-time RT-PCR based on Taqman technology for detecting simultaneously the genome of pan-enterovirus and enterovirus 71.The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways.Emerging and re-emerging epidemic encephalitis: a tale of two viruses.Hand foot and mouth disease due to enterovirus 71 in Malaysia.Alanine scanning mutagenesis of SP70 epitope in characterizing species‑specific antibodies induced by enterovirus 71‑based antigens.Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis.
P2860
Q21245503-A415BEBC-943D-4D59-B110-9409EC21E278Q27334321-459CD24E-EB2E-4EE4-A7B6-BB7C6971963FQ27487827-4D85C5D7-446C-4699-B1F0-48796EA65CFDQ27684518-49A6B72C-46DF-4FB3-8F43-CB61E27D96DCQ28478931-8E1FF933-CE39-4DD0-A39C-C86AC61D8184Q30233446-7A0B5699-FE8A-40B7-A7CB-EA04ABCAF5C6Q30352512-9C79AB97-CAC0-4286-8CAC-8979F7320CD6Q33576597-9011CE79-BE06-41E4-9569-83C4D5CDB556Q33579809-3749130D-5DE1-4D2C-9E31-D2D027962C8DQ33602842-819927C0-B3F2-41BF-A3D7-A315D4120A14Q33685512-845BAF5F-555B-496E-BFC7-896AD72C217AQ34031953-813214EE-0536-4F2D-9A74-F5E29E4B3168Q34215993-3ABB95BF-CC2A-4C5E-A5DC-95E5AC21DBE7Q34958589-97B1F3B7-C058-4F3A-B9D5-2089FF12D9FEQ35041899-27FF8E47-7B6E-42FB-9064-362047473664Q35088457-CF9C4919-5053-4040-B51B-51729D4E7675Q35132329-2B15D3CD-BCB0-4D63-B73F-7E24638FE2C1Q35158936-F8E49E67-0591-482C-8D78-31A135D3AF9AQ35308536-6B69350E-28F9-480B-B753-B0F0AD5F3E0DQ35838900-10CF2279-29BC-4FEF-84B1-12364121E807Q35839349-19335F31-986C-4AF9-A204-1E87F67111C1Q36383178-67F9067D-2E96-46EA-8E22-842DCB061566Q36492811-315396A8-B946-4BCE-8743-A013B21D76C2Q37130763-E9FD7910-A91E-4E8D-A544-36DCE6A02D48Q37347350-FE522349-92F9-447C-93AC-498C4C8C0DDAQ37658853-D215577C-4CE9-4A77-937D-369B89314E0BQ37724652-640B0ADE-502D-49E5-B70F-0D25C01159ABQ38174168-A7303A7E-5E57-482F-912F-411C32034BE1Q38703853-A3CE26F7-BB45-4C2E-8CF2-C3B4FCDFDAB5Q39412134-6DACF79B-54F7-461A-9791-B353184774F6Q39606586-48037C91-5E7C-46E0-BD4A-353EAB9F54A8Q39840971-86ABDDAE-3E37-489B-9E4E-EA07570DE651Q40614108-464D29CA-314A-4AD6-ABBF-05C7AFF070DAQ41932140-784FBAC5-1AE3-4374-85D0-92A8436F2194Q42252303-B87685F4-8802-4CDC-A416-107655C874BBQ42524022-089A4772-003F-419C-B263-C74518EE6BD5Q43778580-46E53988-6240-4B49-A93B-C9F4DAFA4727Q43898042-EBD0A13F-EC6F-453C-9353-A0202FF61DB9Q46266076-4A7ACA11-C5E5-4ADC-881A-D982DF85198AQ50647112-1E330CC3-31DA-4B81-B568-CAE4881D0523
P2860
Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis.
@en
Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis.
@nl
type
label
Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis.
@en
Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis.
@nl
prefLabel
Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis.
@en
Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis.
@nl
P2093
P1433
P1476
Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis.
@en
P2093
P356
10.1016/S0140-6736(05)60789-1
P407
P577
1998-10-01T00:00:00Z